GENETX
GenetX is a biotechnology company. GenetX solution is going to disrupt the diet, wellbeing and nutritional consultancy industry, the time of “Try and Error solution” it passed, time of precision nutrition it comes. We democratize access to information, everybody can find therapeutic nutritional solutions, based on genetic code and other analysis
GENETX
Social Links:
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Voluntari, Bucuresti, Romania
Country:
Romania
Website Url:
http://www.genetx.eu
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Current Employees Featured
Official Site Inspections
http://www.genetx.eu Semrush global rank: 9.9 M Semrush visits lastest month: 86
- Host name: mail-abeb-ij.gazduireweb.ro
- IP address: 81.181.252.90
- Location: Floresti Romania
- Latitude: 46.7333
- Longitude: 23.4833
- Timezone: Europe/Bucharest
- Postal: 407280
More informations about "GenetX"
Team - genetx.eu
Until his departure to GenetX, in 2017, he has successfully implemented 6 projects in the IT and Health industries. Mircea’s multinational experience helped the company win numerous …See details»
Home [www.genetx.eu]
GENETX WITH THEIR PATIENTS Nutrigenetics Woman's Health + Pharmacogenetic Read more » Healthy Life + Pharmacogenetic Read more » ... [email protected] Send us a message …See details»
GenetX - Crunchbase Company Profile & Funding
GenetX is located in Voluntari, Bucuresti, Romania. Who are GenetX 's competitors? Alternatives and possible competitors to GenetX may include Byonoy , Infectex , and UVera .See details»
GenetX - Drug pipelines, Patents, Clinical trials - Synapse
Explore GenetX with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Ophthalmology - genetx.eu
Microphthalmia, Anophthalmia and Anterior Segment Dysgenesis(OP0601) Sequencing (€ 1600) DEL / DUP (€ 900) Plus (€ 1900) Learn moreSee details»
Bogdan Ivanov - CEO @ GenetX - Crunchbase Person Profile
Primary Organization . GenetX . Location Ilfov, Romania, Europe; Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male; LinkedIn View on LinkedIn ; Bogdan …See details»
FAQ on GeneTx Acquisition - FAST
As noted, GeneTx and Ultragenyx have been working together to conduct a Phase 1/2 clinical study of GTX-102 in the U.S., Canada and the United Kingdom. In July, Ultragenyx exercised …See details»
GenetX - Overview, News & Similar companies | ZoomInfo.com
View GenetX (www.genetx.eu) location in Bucuresti, Romania , revenue, industry and description. Find related and similar companies as well as employees by title and much more. ... GenetX. …See details»
From Hope to a Potential First Therapy for Angelman
Jul 18, 2022 Ultragenyx and GeneTx Provide Program Update on GTX-102 for Angelman Syndrome Including Promising Interim Data from Phase 1/2 Study – Press Release, 18-July-2022; Paula Evans is founder of the Foundation for …See details»
GeneTx Company Profile 2024: Valuation, Investors, Acquisition
GeneTx General Information Description. Developer of antisense drugs designed for the treatment of rare genetic disorders. The company's treatment includes an antisense therapy …See details»
GeneTx Biotherapeutics Company Profile | Management and
GeneTx Biotherapeutics LLC is a startup biotechnology company singularly focused on developing and commercializing a safe and effective antisense therapeutic for the treatment of …See details»
Endocrinology - genetx.eu
Abnormal Genitalia/ Disorders of Sex Development(EN0201) Sequencing (€ 1600) DEL / DUP (€ 900) Plus (€ 1900) Learn moreSee details»
GenetX Company Profile - Office Locations, Competitors, Revenue …
GenetX is a company that provides genetic tests (nutrigenetic, genetic diagnostic, pharmacogenetic). It analyzes and tracks blood, urine, genetic, and digital markers, monitors …See details»
GeneTx Biotherapeutics Update for AS Community - FAST
GeneTx shares updates on GTX-102 developments and future plans for Angelman syndrome therapies, emphasizing their ongoing commitment and recent milestones. ... FAST is the …See details»
GeneTx and Ultragenyx Receive Approval from U.K. Regulatory …
Jun 10, 2021 GeneTx Biotherapeutics LLC is a startup biotechnology company singularly focused on developing and commercializing a safe and effective antisense therapeutic for the …See details»
Ultragenyx ready to sign away $75M for Angelman partner GeneTx
Jul 18, 2022 After an interim data drop late Monday afternoon, Ultragenyx is exercising its right to acquire partner GeneTx for $75 million upfront, bringing a drug the two companies have …See details»
GeneTx Biotherapeutics - Overview, News & Similar companies
Dec 1, 2021 GeneTx Biotherapeutics LLC is a startup biotechnology company singularly focused on developing and commercializing a safe and effective antisense t herapeutic for the …See details»
What you do / What we do - genetx.eu
GenetX will reveal what you don't know about you analyzing genetic variations from your DNA. All genetic tests (Nutrigenetic, Genetic Diagnostic, Pharmacogenetic) at your finger. ...See details»
GeneTx and Ultragenyx Receive Clearance from Health Canada
May 19, 2021 GeneTx Biotherapeutics LLC is a startup biotechnology company singularly focused on developing and commercializing a safe and effective antisense therapeutic for the …See details»
Russia's Sergei Lavrov makes first visit to EU since Ukraine invasion …
2 days ago Russia's Foreign Minister Sergei Lavrov has travelled to Malta for a European security summit, marking his first visit to an EU state since the full-scale invasion of Ukraine.See details»